Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
Magnesium is neuroprotective in neonatal animal models of acquired hypoxic-ischemic and/or
inflammatory cerebral lesions. It is associated with a significant reduction of perinatal
death and cerebral palsy in some observational studies.
The objective of the study is to assess if prenatal magnesium sulfate given to women at risk
of preterm birth before 33 week's gestation is neuroprotective.